magnesium sulfate
in review
2 min read
Updated 2026-10-30
eclampsia / preeclampsia
4 g IV over 20 min → 1 g/h
until 24 h after last seizure or birth
recurrent seizure
2 g IV
over 5–10 min
magnesium sulfate
First-line for treatment and prevention of eclamptic seizures. Not an antihypertensive. Renally cleared — toxicity is monitored clinically (reflexes, RR, urine output), with calcium gluconate as antidote.
mechanism
NMDA antagonism + cerebral vasodilation (relieves vasospasm); calcium-channel blockade at the neuromuscular junction (→ toxicity profile).
dosing
| indication | regimen |
|---|---|
| eclampsia / preeclampsia prophylaxis | 4 g IV in 100 mL NS over 20 min → 1 g/h, until 24 h after last seizure or birth (whichever later) |
| IM (no IV, or transport) | 4 g IV (if possible) + 5 g IM each buttock (10 g; can add 2 mL 1% lidocaine) → 5 g IM one buttock q4h |
| IM → IV switch | start 1 g/h (no load) when next IM dose due |
| recurrent seizure on infusion | additional 2 g IV over 5–10 min |
| AKI / oliguria | full loading dose; reduce or hold maintenance; check level |
| severe acute asthma (non-obstetric dose) | 2 g IV over 20 min, single dose |
- ACOG range 1–2 g/h maintenance; SOGC uses 1 g/h
- SOGC indications: treatment of eclampsia; prophylaxis in preeclampsia with severe HTN or any adverse condition; foetal neuroprotection if delivery imminent <33⁺⁶ wk
key points
- Severe BP and seizure risk need separate treatment — normalised BP doesn’t remove the Mg indication
- Phenytoin, benzodiazepines inferior for eclampsia
- SOGC monitoring: reflexes after load and hourly; BP, HR, RR, SpO₂ q30 min; urine output hourly (Foley)
- Toxicity triggers: absent reflexes, RR <12 for 15 min, SpO₂ <94% for 15 min, urine <30 mL/h for 4 h, drowsiness/slurred speech
- Levels only if ↓ renal function or suspected toxicity
- Nifedipine + Mg can be given together (SOGC) — no ↑ serious Mg-related adverse effects
- Prolongs neuromuscular blockade — tell anaesthesia
toxicity — act on clinical signs, not the level
Loss of reflexes → somnolence, slurred speech → respiratory depression → cardiac arrest. Stop infusion, send Mg level → calcium gluconate 10% 10 mL (1 g) IV over 3 min → support ventilation; dialysis if renal failure.
| serum Mg (mmol/L) | effect |
|---|---|
| 2.0–3.5 | therapeutic |
| >3.5–5 | loss of patellar reflexes |
| >5–6.5 | respiratory depression |
| >7.5 | cardiac conduction defects, arrest |
adverse effects
- Flushing, warmth, nausea, muscle weakness (expected)
- Hypotension (mild), pulmonary oedema with fluid overload
- Neonatal hypotonia/respiratory depression with prolonged use
evidence
- Magpie (2002) — n≈10,000 with preeclampsia; eclampsia 0.8% vs 1.9% (RRR 58%); trend to lower maternal mortality; no foetal harm
Prepared 2026-10-30. Not yet verified — check every number against the sources.